Spero Therapeutics, Inc.

SPRO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
4 Jun 16, 2025 4
8-K May 28, 2025 8-K
8-K May 13, 2025 8-K
10-Q May 13, 2025 10-Q
4 May 6, 2025 4
ARS Apr 28, 2025 ARS
DEFA14A Apr 28, 2025 DEFA14A
DEF 14A Apr 28, 2025 DEF 14A
8-K Apr 28, 2025 8-K
SCHEDULE 13D/A Mar 28, 2025
8-K Mar 27, 2025 8-K
10-K Mar 27, 2025 10-K
8-K Feb 28, 2025 8-K
4 Feb 5, 2025 4
4 Feb 5, 2025 4
4 Feb 5, 2025 4
4 Feb 5, 2025 4
8-K Jan 10, 2025 8-K
SC 13G/A Nov 14, 2024 SC 13G/A
8-K Nov 14, 2024 8-K
10-Q Nov 14, 2024 10-Q
4 Nov 12, 2024 4
8-K Oct 29, 2024 8-K
8-K Sep 10, 2024 8-K
4 Aug 29, 2024 4
← Newer Page 3 of 21 · 513 filings Older →